Sphere Medical Holding (LSE:SPHR) Cash Flow from Financing : £-0.07 Mil (TTM As of Dec. 2016)

View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2016, Sphere Medical Holding paid £0.00 Mil more to buy back shares than it received from issuing new shares. It received £0.00 Mil from issuing more debt. It paid £0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received £0.00 Mil from paying cash dividends to shareholders. It received £0.00 Mil on other financial activities. In all, Sphere Medical Holding spent £0.00 Mil on financial activities for the six months ended in Dec. 2016.

Sphere Medical Holding Cash Flow from Financing Historical Data

The historical data trend for Sphere Medical Holding's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Cash Flow from Financing Chart

Sphere Medical Holding Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Cash Flow from Financing

Get a 7-Day Free Trial

-0.04

8.51

0.01

12.34

-0.07

Sphere Medical Holding Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
Cash Flow from Financing	Get a 7-Day Free Trial						-0.01	12.35	-	-0.07	-

Sphere Medical Holding Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Sphere Medical Holding's Cash from Financing for the fiscal year that ended in Dec. 2016 is calculated as:

	Cash Flow from Financing		(A: Dec. 2016 )
=	Issuance of Stock	+	Repurchase of Stock	+	Net Issuance of Debt	+	Net Issuance of Preferred Stock	+	Cash Flow for Dividends	+	Other Financing
=	0	+	0	+	0	+	0	+	0	+	0
=	0.00

Sphere Medical Holding's Cash from Financing for the quarter that ended in Dec. 2016 is:

	Cash Flow from Financing		(Q: Dec. 2016 )
=	Issuance of Stock	+	Repurchase of Stock	+	Net Issuance of Debt	+	Net Issuance of Preferred Stock	+	Cash Flow for Dividends	+	Other Financing
=	0	+	0	+	0	+	0	+	0	+	0
=	0.00

Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.07 Mil.

Sphere Medical Holding (LSE:SPHR) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Sphere Medical Holding's issuance of stock for the six months ended in Dec. 2016 was £0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Sphere Medical Holding's repurchase of stock for the six months ended in Dec. 2016 was £0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Sphere Medical Holding's net issuance of debt for the six months ended in Dec. 2016 was £0.00 Mil. Sphere Medical Holding received £0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Sphere Medical Holding's net issuance of preferred for the six months ended in Dec. 2016 was £0.00 Mil. Sphere Medical Holding paid £0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Sphere Medical Holding's cash flow for dividends for the six months ended in Dec. 2016 was £0.00 Mil. Sphere Medical Holding received £0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Sphere Medical Holding's other financing for the six months ended in Dec. 2016 was £0.00 Mil. Sphere Medical Holding received £0.00 Mil on other financial activities.

Sphere Medical Holding Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Sphere Medical Holding (LSE:SPHR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Cash Flow from Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harston Mill, Harston, Cambridge, GBR, CB22 7GG

Website

http://www.spheremedical.com

Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.